
PSU banks trading below book value despite healthy ROE: Krishna Sanghavi
banks
are trading below book value, according to
Krishna Sanghavi
, CIO-Equity at Mahindra Manulife. This
valuation
anomaly comes at a time when the fund house is launching a dedicated
BFSI
sectoral fund, betting on India's demographic dividend and the ongoing financialization of savings in a formal economy.
In this conversation, Sanghavi explains why BFSI offers both cyclical rebound potential in lending and secular growth in non-lending businesses, while discussing how the sector's composition has evolved dramatically—with banks' share of BFSI market cap shrinking from 85% to 57% over two decades, creating opportunities across insurance, AMCs, NBFCs, and capital market intermediaries.
Edited excerpts from an interview:
What's the core thesis behind launching a sectoral fund focused on BFSI at this market juncture? Are you betting on a cyclical rebound or a structural re-rating?
BFSI is a core play on India's demographics, rising per capita income amidst the financialization of savings in a formal economy. Overall, we expect the penetration of different financial products to rise. More Indians are likely to enter higher income strata and can contribute to BFSI sectors' growth either as a saver or borrower (lending), investor (asset management or capital market or life insurance) or seeking protection (life insurance or general insurance). We see it as a combination of cyclical rebound (lending) in line with the economy and secular growth (non-lending businesses).
Additionally, there are opportunities for earnings growth and valuations within the various micro-segments in BFSI. Banks, both private and PSUs, have healthy balance sheets and return ratios with minimal asset quality issues. Moreover, the
Nifty Financial Services
index underperformed the Nifty 500 index in four out of the last five calendar years. Valuations are reasonable and earnings outlook is also improving. The Nifty Financial Services index has already shown signs of revival, outperforming the broader Nifty 500 index by nearly 9.8% in the January to June 25 period. While liquidity has improved, we are yet to see improvement in deposit and credit growth, which could play out as the year progresses, supporting our positive views on the overall BFSI sector.
Expect credit quality to remain good and steady growth to help BFSI maintain broad participation in the profit pool.
BFSI is already one-third of India's market cap and profit pool. What's the incremental opportunity you see, and how differentiated can this fund be from existing diversified funds?
Within BFSI, companies in sub-sectors such as lending, asset management, and wealth fund will thus be a standalone play on the BFSI theme, compared to our diversified funds where BFSI is only a part of the overall portfolio sectoral continuity of earnings from fund will thus be a standalone play on the BFSI theme compared to our diversified funds, where BFSI is only a part of the overall portfolio sectoral portfolio.
While banking has been the traditional heavyweight, how are you looking at the broader spectrum—insurance, AMCs, fintechs, NBFCs? Which segments excite you the most today?
As income levels rise, customers start shifting from savers to either borrowers or investors. This creates wider opportunities for those businesses. When we examine history, in March 2005, Banks constituted nearly 85% of the BFSI market capitalisation, now make up only 57% of the BFSI market capitalisation, while 2—Various from NBFCs and the remaining 20% from segment BFSI financial services companies has continued to rise with their strong earnings growth and news has kept on rising with their strong earnings growth and also newer listings. Each of these financial services segments brings in its own set of opportunities and challenges. Insurance companies have seen healthy growth, driven by rising penetration. Asset managers have seen rapid AUM growth in the last few years, thanks to rising incomes & shift towards investing, partly helped by strong market returns. On the fintech side, there have only been a couple of listings till now and a few others are expected to get listed soon. We believe these segments offer a reasonable growth opportunity.
With valuations in private banks and NBFCs at or below long-term averages, do you see this as a compelling entry point or is it more about selective positioning?
Yes, equity portfolio construct would always be about selective positioning based on stock specific criteria like growth, management and valuations. At times this gets impacted due to distortions of ownership or inclusion/exclusion in ETFs. Also, it is part of the investing cycles that at any point, some companies trade at higher or lower than long term average. Overall, we see a healthy environment with a supportive monetary policy on both lower rates as well as higher liquidity and this can help few lenders based on their asset liability mix.
How do you perceive the growth opportunity in PSU bank stocks?
The PSU banks have gone through a healthy consolidation (mergers), governance reforms & balance sheet improvement. The balance sheet has strengthened with higher capital adequacy, and the narrative on PSU stocks has improved due to diversification into retail lending and recoveries from corporate loans. Operationally, the digital rollout is helping and so is control over total employees. Higher capital would help them grow lending when the corporate capex cycle picks up. From a valuation perspective, quite a few PSU banks are trading below book value despite healthy ROA &
ROE
in FY25.
Capital market intermediaries have become significant in BFSI's narrative and an investor favourite as well. Do you see them as consistent compounders?
Capital market players have a good growth potential as India moves from being a nation of savers to a nation of investors. Rising per capita income as well as younger demography creates new customer segments who are looking at risk-return trade-offs on their investments. One advantage for these businesses is they don't require much capital for growth and hence a good execution led by digital distribution can help them grow sustainably at higher rates. The BFSI universe includes quite a few capital market intermediaries and we expect more investible opportunities from future listings. However, some of these businesses are cyclical and hence a focus on earning sustainability and valuations is a must.
In between the two ends of banks and NBFCs, the tilt has largely been in favour of the latter in a rate cut cycle. But given the valuations for both, which one would you be more biased towards?
The fact that banks may face margin pressure in a rate cut cycle and NBFCs may benefit is largely known. So, NBFCs have done well in the last year and now valuations for few NBFCs are higher relative to banks. Based on the investment timeframe being short or medium term, the rate cut cycle would start supporting the cost of funds for banks with a time-lag based on their liability franchise, maturity structure and rate cut on savings deposits. The CRR cut and easy liquidity too would help.
India's insurance sector remains underpenetrated despite a decade of liberalization. What's the investment case for life vs general insurance at this stage?
The outlook for the life insurance segment looks healthy at the moment given these companies faced VNB margin pressure in FY25 due to higher salience of ULIP sales in their mix. The product mix can be more balanced this year, aiding the margin growth. The general insurance segment is seeing slower growth on the motor segment while health insurance segment growth is strong though not very profitable. With the upcoming regulatory norms on expense management, the profitability of the general insurance sector could show improvement as insurers adhere to expense and commission caps. From the investor side, expected IFRS implementation in the next 2 years will help reduce the gap between accounting profits and VNB profits. Another regulatory support is the expected reduction in GST rate that can make insurance products more affordable. So, both Life & General insurance makes a good investment case from a longer term.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
40 minutes ago
- Time of India
Improved consumption trends bring cheer to FMCG counters
Mumbai: Shares of fast-moving consumer goods (FMCG) firms advanced Monday after Godrej Consumer's quarterly business update pointed to improved demand prospects. Godrej is the third company after Dabur and Marico to signal a stronger-than-expected growth outlook, but some analysts warn against painting these performances as an industry-wide trend. "A sequential improvement in volume growth and revenue growth indicated by Godrej Consumer Products , Dabur and Marico led to renewed investor sentiment," said Ajay Thakur, research analyst - FMCG, Anand Rathi Institutional Equities. "A good monsoon is seen propping up rural demand and an uptick in urban demand also supports sentiment." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo The Nifty FMCG Index gained 1.7% on Monday, while the benchmark Nifty remained flat. Of the 15 stocks on the FMCG Index, 13 advanced and two declined. Agencies Godrej Consumer jumped 6.4%, leading the gains in FMCG stocks. Dabur gained 3.5%, while HUL and Emami rose over 2.5% each. Britannia Industries climbed 2.1%, and Varun Beverages and Tata Consumer advanced 1.7% and 1.5%, respectively. While the pickup in volumes is expected to stronger in the second half of FY26, gains might be limited to stocks that offer better growth prospects. "The positive guidance was largely for Godrej Consumer and Marico but since the FMCG stocks have been beaten down, the other stocks also rose in hopes of a recovery," said Amit Purohit, VP, Elara Capital. "Although second half is anticipated to be better, Q1 is expected to be muted." Live Events Godrej Consumer Products said in its quarterly update that the volume growth is improving from the previous quarter, and the company expects double-digit rupee revenue growth on the back of high single-digit volume growth. Dabur's growth guidance is softer than that of Godrej, but investors were expecting far worse. "There were expectations of flat to declining growth in Dabur, but the company expects low single-digit growth, which might be perceived optimistically in the otherwise lacklustre quarterly update," said Purohit. So far this year, the Nifty FMCG Index has declined 2%, while the benchmark Nifty has gained 7.7% in the same period. Thakur said he prefers Godrej Consumer among large cap FMCG stocks, while Dabur's valuations are attractive. Purohit said investors should focus on specific stocks in the sector based on their reported growth. "Godrej Consumer Products and Marico are clear standouts and as the market rewards growth, gains are likely in these stocks," said Purohit. "Other stocks may move up as the narrative around the government focus on consumption, good monsoon, and base effect to play out."


Economic Times
43 minutes ago
- Economic Times
Improved consumption trends bring cheer to FMCG counters
Mumbai: Shares of fast-moving consumer goods (FMCG) firms advanced Monday after Godrej Consumer's quarterly business update pointed to improved demand prospects. Godrej is the third company after Dabur and Marico to signal a stronger-than-expected growth outlook, but some analysts warn against painting these performances as an industry-wide trend. ADVERTISEMENT "A sequential improvement in volume growth and revenue growth indicated by Godrej Consumer Products, Dabur and Marico led to renewed investor sentiment," said Ajay Thakur, research analyst - FMCG, Anand Rathi Institutional Equities. "A good monsoon is seen propping up rural demand and an uptick in urban demand also supports sentiment." The Nifty FMCG Index gained 1.7% on Monday, while the benchmark Nifty remained flat. Of the 15 stocks on the FMCG Index, 13 advanced and two declined. Godrej Consumer jumped 6.4%, leading the gains in FMCG stocks. Dabur gained 3.5%, while HUL and Emami rose over 2.5% each. Britannia Industries climbed 2.1%, and Varun Beverages and Tata Consumer advanced 1.7% and 1.5%, respectively. While the pickup in volumes is expected to stronger in the second half of FY26, gains might be limited to stocks that offer better growth prospects."The positive guidance was largely for Godrej Consumer and Marico but since the FMCG stocks have been beaten down, the other stocks also rose in hopes of a recovery," said Amit Purohit, VP, Elara Capital. "Although second half is anticipated to be better, Q1 is expected to be muted."Godrej Consumer Products said in its quarterly update that the volume growth is improving from the previous quarter, and the company expects double-digit rupee revenue growth on the back of high single-digit volume growth. ADVERTISEMENT Dabur's growth guidance is softer than that of Godrej, but investors were expecting far worse. "There were expectations of flat to declining growth in Dabur, but the company expects low single-digit growth, which might be perceived optimistically in the otherwise lacklustre quarterly update," said Purohit. So far this year, the Nifty FMCG Index has declined 2%, while the benchmark Nifty has gained 7.7% in the same period. Thakur said he prefers Godrej Consumer among large cap FMCG stocks, while Dabur's valuations are attractive. ADVERTISEMENT Purohit said investors should focus on specific stocks in the sector based on their reported growth."Godrej Consumer Products and Marico are clear standouts and as the market rewards growth, gains are likely in these stocks," said Purohit. "Other stocks may move up as the narrative around the government focus on consumption, good monsoon, and base effect to play out." (You can now subscribe to our ETMarkets WhatsApp channel)


Mint
an hour ago
- Mint
Best stocks to buy today, 8 July, recommended by NeoTrader's Raja Venkatraman
A lacklustre day seems to be leading to a hard time, as we were unable to trigger any further negative bias. As we contemplate further action, we should continue to participate, albeit in a limited fashion, as the markets are not able to sustain the intraday decline, hinting at a possible breakout of resistance zones. Here are three stocks to trade, as recommended by Raja Venkatraman of NeoTrader for Tuesday, 8 July: SUVEN: Buy CMP and dips to ₹255 | Stop ₹245 | Target ₹295-310 TIRUMALCHM: Buy CMP and dips to ₹275 | Stop ₹267 | Target ₹310 TEGA: Buy CMP and dips to ₹1,680 | Stop ₹1,660 | Target ₹1,925-1,990 Market update Benchmark indices ended largely unchanged, with the Nifty lingering around 25,450 as investors adopted a cautious stance ahead of anticipated developments in a US-India mini trade deal later this evening. At closing, the Sensex gained 193.42 points, or 0.23%, to finish at 83,432.89, while the Nifty rose 55.7 points, or 0.22%, to 25,461. Broader markets lagged, with the MidCap index slipping 0.27% and the SmallCap index down 0.40%. Banking and IT stocks outperformed; energy lagged. There are reports that the customs component of the mini deal may be announced today, with remaining details to follow in subsequent phases. Outlook for trading The market remains muted, triggered by geopolitical tensions. The market tested our patience on Monday, but did not give up the lower levels. However, the trend seen over the last few days highlights that the Nifty managed to hold on and did not give up. In the last report, we mentioned, 'From the charts above, we can see that the trends are down into some strong set of supports yet again." On the charts, we note that the doji formation on Monday continues to keep us guessing. Taking some cues from the Option data, we can add that the levels around 25,450 that had steady Put writers have now ensured that the upward possibility gets more wings. With the PCR nearing 0.80, we can expect some trended move today. Stay alert. The trend that is emerging clearly suggests that the dips seen last week managed to hold the support zone, and the gap-down opening was covered to ensure that the prices traded above the range area that developed in the last few days. Hence, one should track the trends that are in progress as the up move needs to continue its way above 25,000 (Nifty Spot)to renew the bullish bias. Momentum on hourly charts is indicating that the prices after settling down seem to have witnessed a resumption of selling pressure. With the gradual and hesitant rise emerging from lower levels, we can expect the rise to remain hesitant. For shorts, we need to see the Nifty move above 25,300, which is immediate support as per the Open Interest data. If we witness a 30-minute range breakout on Tuesday, we can consider trading on either side as the trends remain tentative, and we expect some resistance to kick in. While the trends in the indices are still unclear, there is plenty of action as far as the stocks are concerned. Three stocks to trade, recommended by NeoTrader's Raja Venkatraman: Suven Life Sciences Ltd (Cmp 267.85) Why it's recommended: Suven Life Sciences Ltd is experiencing notable buying interest, with significant gains over various time frames. The stock has shown impressive growth in recent months and is trading near its 52-week high. It has maintained a bullish trend, outperforming broader market indices. As the prices have now managed to clear from its recent consolidation spanning more than 2 months, we can look to trade the upmove. Consider going long. Key metrics: P/E: 109.31 | 52-week high: ₹271.72 | Volume: 377.63K. Technical analysis: Support at ₹218 | Resistance at ₹350. Risk factors: Market volatility and slowdown in global markets and industry-specific challenges. Buy at: CMP and dips to ₹255. Target price: ₹295-310 in 1 month. Stop loss: ₹245. Thirumalai Chemicals Ltd (Cmp 291.55) Why it's recommended: The prices have been moving in a tight range, but at the same time, steady volume interest at lower levels has been holding the bullish bias. A long body candle on Monday has once again triggered some bullish possibilities in the coming sessions. With momentum picking up, one can look to buy. Key metrics: P/E: 36.02 | 52-week high: ₹395 | Volume: 555.53K. Technical analysis: Support at ₹225, resistance at ₹350. Risk factors: Rising input costs, increased operational expenses, and potentially foreign exchange impacts. Buy at: CMP and dips to ₹275. Target price: ₹310 in 1 month. Stop loss: ₹267. Tega Industries Ltd (Cmp 1755.30) Why it's recommended: The trends are remaining consistent and are showing a consistent rounding pattern, indicating that the momentum remains poised for more upside. Volumes saw a major uptick on Monday, indicating that the prices are giving a good follow-through post the value resistance area breakout. Key metrics: P/E: 66.43 | 52-week high: ₹2,327.45 | Volume: 530.66K. Technical analysis: Support at ₹1475, resistance at ₹2300. Risk factors: Rising input costs, increased operational expenses, and potentially foreign exchange impacts. Buy at: CMP and dips to ₹1,680. Target price: ₹1,925-1,990 in 1 month. Stop loss: ₹1,660. Raja Venkatraman is the co-founder of NeoTrader. His Sebi-registered research analyst registration no. is INH000016223. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantees performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.